We are pleased to announce that Setolabo has been selected for the FY2025 “Healthcare Industry Global Expansion Support Program”,
implemented by the Ministry of Economy, Trade and Industry (METI) and the Medical Excellence Japan (MEJ).
This program aims to support Japanese companies with outstanding healthcare technologies and services in their overseas expansion efforts.
It promotes collaboration with international medical institutions to address local healthcare challenges and foster sustainable global growth.
Through collaborative research with domestic medical institutions, Setolabo has been developing advanced diagnostic technologies
for the early detection of cancer and conducting clinical studies to validate their effectiveness.
Building on this selection, we will further leverage our AI-based analytical technologies and data-driven research expertise
to conduct international demonstration studies and strengthen cross-border medical collaboration.
Our goal is to accelerate the implementation of community-based preventive healthcare models that benefit people around the world.
For more information, please refer to the
“List of Selected Projects for the FY2025 Healthcare Industry Global Expansion Support Program” published by METI and MEJ.
We sincerely appreciate your continued support and interest in Setolabo’s ongoing efforts to advance preventive healthcare and global medical innovation.